Jörg Heeren

Professor Jörg Heeren serves in the Department of Biochemistry and Molecular Cell Biology at Universitätsklinikum Hamburg-Eppendorf (UKE), where he has established himself as a leading researcher in lipid metabolism and metabolic disorders. His academic trajectory shows continuous research activity from 2010 through 2022, with leadership roles in multiple German Research Foundation (DFG) funded projects including SFB 1328 and several iterations of SFB 841.

His research interests focus on lipid metabolism, adipose tissue biology, and liver disease pathogenesis, particularly examining the connections between lipid processing, inflammation, and metabolic disorders. Dr. Heeren's work frequently explores the role of bile acids, energy expenditure mechanisms, and inflammatory pathways in conditions like non-alcoholic steatohepatitis (NASH). His laboratory investigates both fundamental biochemical mechanisms and potential therapeutic approaches for metabolic diseases.

Analysis of his recent publications reveals a strong emphasis on lipidomics, adipose tissue immunometabolism, and hepatic lipid processing. His research spans from basic molecular mechanisms to clinical implications, with particular attention to sex differences in metabolic responses and the impact of circadian rhythms on lipid metabolism. The work often involves sophisticated in vivo models and translational approaches connecting basic science to potential clinical applications.

Dr. Heeren has contributed significantly to understanding how extracellular adenosine, bile acids, and various signaling molecules regulate metabolic processes in adipose tissue and liver. His research has implications for treating obesity-related complications, type 2 diabetes, and fatty liver diseases.